The BioArte Ltd is an innovative biotechnology company based in 88, dedicated to advancing biomolecular and microbiome research. Specializing in the study of human microbiota and microbial ecosystems, The BioArte focuses on understanding both beneficial and pathogenic microorganisms to improve diagnostics and health outcomes.
With over 25 years of scientific and clinical experience, the company’s founders have played a pioneering role in microbiome science and immune system research. Their work has led to key discoveries in how the immune system interacts with microbes and how microbiota-derived molecules can influence health and disease.
The BioArte is committed to developing next-generation microbiome-based diagnostic tools and personalized therapeutic solutions derived from human and animal microbiota. Operating between two leading research facilities in 88, The BioArte continues to push the boundaries of molecular biology, immunology, and personalized medicine — helping to transform how diseases are detected, understood, and treated.